SynopsisSignifor is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. The global Signifor Drugs market was valued at US$ 104.5 million in 2023 and is antici.....
SynopsisLanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome The global Lanreotide Drugs market was valued at US$ 1401 million in 2023 and is anticipated to reach US$ .....
SynopsisSomatuline is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome The global Somatuline Drugs market was valued at US$ 1401 million in 2023 and is anticipated to reach US$ 1506.5.....
SynopsisPegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Pegvisomant market was valued at US$ 268 million in 2023 and is anticipated to reach US$ 331.5 million by 2030, witnessing a CAGR of .....
SynopsisPegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Somavert market was valued at US$ 268 million in 2023 and is anticipated to reach US$ 331.5 million by 2030, witnessing a CAGR of 3.1.....
SynopsisPegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Pegvisomant Drugs market was valued at US$ 268 million in 2023 and is anticipated to reach US$ 331.5 million by 2030, witnessing a CA.....
SynopsisPegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Somavert Drugs market was valued at US$ 268 million in 2023 and is anticipated to reach US$ 331.5 million by 2030, witnessing a CAGR .....
SynopsisAcromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly. The global Acromegaly Therapeutics market was valued at US$ 2964 million in 2023 and is anticipa.....
SynopsisAcromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly. The global Acromegaly Drugs market was valued at US$ 2964 million in 2023 and is anticipated to .....
SynopsisHemin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. The global Hemin market was valued at US$ 49 million in 2023 and is anticipated to reach US$ 56 million by 2.....
